Atossa Genetics Inc (NASDAQ:ATOS) Stock was panned all round at the markets during trading on 4th March, which led to the market valuation of the diagnostic substance and medical equipment manufacturer taking a 11.3 percent hit during the day’s trading. Atossa Genetics Inc (NASDAQ:ATOS) stock opened at $1.86 in last session, and closed at $1.85, while the day range of stock is $1.81 – $1.86. The stock showed a negative weekly performance of -18.50%.
Venaxis, Inc. (NASDAQ:APPY)is developing a promising diagnostic tool showing ~97% accuracy in negative test results at a significantly cheaper financial cost and zero radioactive side effects. Venaxis Inc (NASDAQ:APPY) stock opened at $2.64, in last session and closed at $2.59, by losing -1.89%. The 52 week range of the stock is $1.15 – $2.85. Company’s market capitalization is $55.57 million.
IDEXX Laboratories Inc. (NASDAQ:IDXX) participated in the Raymond James 35th Annual Institutional Investors Conference. IDEXX Laboratories, Inc. (NASDAQ:IDXX) stock advanced 0.53% and finished the last session at $126.67. The EPS of the stock remained 3.52. Company’s market capitalization is $6.54 billion.
Shares of AMAG Pharmaceuticals (NASDAQ:AMAG) were the recipient of a significant growth in short interest in the month of January. As of February 14th, there was short interest totalling 1,594,585 shares, a growth of 83.0% from the January 31st total of 871,197 shares, Stock Ratings News reports. AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) stock opened the session at $22.00, and closed the session at $21.88. The 52 week range of the stock remained $17.76 – $28.42 and the day range was $21.71 – $22.39.